These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 8388015
1. Effects of FSH and testosterone on intratesticular insulin-like growth factor-I and specific germ cell populations in rats treated with gonadotrophin-releasing hormone antagonist. Spiteri-Grech J, Weinbauer GF, Bolze P, Chandolia RK, Bartlett JM, Nieschlag E. J Endocrinol; 1993 Apr; 137(1):81-9. PubMed ID: 8388015 [Abstract] [Full Text] [Related]
2. Effects of flutamide on testicular involution induced by an antagonist of gonadotrophin-releasing hormone and on stimulation of spermatogenesis by follicle-stimulating hormone in rats. Chandolia RK, Weinbauer GF, Fingscheidt U, Bartlett JM, Nieschlag E. J Reprod Fertil; 1991 Nov; 93(2):313-23. PubMed ID: 1787450 [Abstract] [Full Text] [Related]
6. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). van Roijen JH, Ooms MP, Weber RF, Brinkmann AO, Grootegoed JA, Vreeburg JT. J Androl; 1997 Nov; 18(1):51-61. PubMed ID: 9089068 [Abstract] [Full Text] [Related]
11. Restoration of testicular transferrin, insulin-like growth factor-1 (IGF-1), and spermatogenesis by exogenously administered purified FSH and testosterone in medically hypophysectomized rats. Itoh N, Nanbu A, Tachiki H, Akagashi K, Nitta T, Mikuma N, Tsukamoto T, Kumamoto Y. Arch Androl; 1994 Nov; 33(3):169-77. PubMed ID: 7857168 [Abstract] [Full Text] [Related]
12. Time course of recovery of spermatogenesis and Leydig cell function after cessation of gonadotropin-releasing hormone antagonist treatment in the adult rat. Hikim AP, Swerdloff RS. Endocrinology; 1994 Apr; 134(4):1627-34. PubMed ID: 8137724 [Abstract] [Full Text] [Related]
13. Temporal and stage-specific changes in spermatogenesis of rat after gonadotropin deprivation by a potent gonadotropin-releasing hormone antagonist treatment. Sinha-Hikim AP, Swerdloff RS. Endocrinology; 1993 Nov; 133(5):2161-70. PubMed ID: 8404667 [Abstract] [Full Text] [Related]
16. Testosterone maintains pituitary and serum FSH and spermatogenesis in gonadotrophin-releasing hormone antagonist-suppressed rats. Rea MA, Marshall GR, Weinbauer GF, Nieschlag E. J Endocrinol; 1986 Jan; 108(1):101-7. PubMed ID: 3003219 [Abstract] [Full Text] [Related]
17. Testosterone and dihydrotestosterone, but not estradiol, selectively maintain pituitary and serum follicle-stimulating hormone in gonadotropin-releasing hormone antagonist treated male rats. Arslan M, Weinbauer GF, Khan SA, Nieschlag E. Neuroendocrinology; 1989 Apr; 49(4):395-401. PubMed ID: 2497399 [Abstract] [Full Text] [Related]